Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency (Q42668786)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2005

Language	Label	Description	Also known as
English	Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency	scientific article published on October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

David B. Dunger

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Kevin C J Yuen

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Jan Frystyk

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Deborah K White

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Th B Twickler

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hans P F Koppeschaar

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Philip E Harris

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Linda Fryklund

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Peter R Murgatroyd

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

428-436

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Adult-onset growth hormone deficiency: Relation of postprandial dyslipidemia to premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Cardiovascular disease and risk factors in adults with hypopituitarism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

A dose titration model for recombinant GH substitution aiming at normal plasma concentrations of IGF-I in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Increased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Disturbed secretion of mutant adiponectin associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Free insulin-like growth factors (IGF-I and IGF-II) in human serum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Growth hormone replacement therapy for adults: into the new millennium.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Insulin-like growth factors and pancreas beta cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02359.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2005.02359.X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42668786&oldid=2218513655"